Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy

Adv Neurol. 1996:69:545-50.

Authors

E Melamed¹, J Zoldan, G Friedberg, I Ziv, A Weizmann

Affiliation

¹ Department of Neurology, Beilinson Medical Center, Petah Tiqva, Israel.

PMID: 8615179

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antiparkinson Agents / adverse effects*
Antiparkinson Agents / therapeutic use
Humans
Levodopa / adverse effects*
Levodopa / therapeutic use
Parkinson Disease / complications
Parkinson Disease / drug therapy
Parkinson Disease / psychology*
Psychoses, Substance-Induced / etiology
Psychoses, Substance-Induced / psychology
Serotonin / physiology*

Substances

Antiparkinson Agents
Serotonin
Levodopa